View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200 / Cisplatin 75 / Gemcitabine 1000, Non-Small Cell Lung Cancer, Neoadjuvant, Cycle 1-4
Protocol-ID: 2376 V1.0 (Mini), PEMB200/CISP75/GEMC1000, NSCLC, neoadj., cycle 1-4Indication(s)
- Lung Carcinoma, Non-Small Cell (Squamous Cell Carcinoma); ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 27.06.2023